0 results for 'Analgesic'
Tempanol Too Similar To Tylenol, District Judge Rules
The makers of Tylenol have one less headache now that a federal judge has issued an injunction forcing a competitor to stop using the brand name "Tempanol" for a dental pain relief medication. The judge found that Tylenol, with more than $1 billion in annual sales, has become a household name and is therefore entitled to extra protection under the Federal Trademark Dilution Act.Ban Jerks to Boost the Bottom Line
If executives believe people are of value, then the question is how to go about managing, motivating and inspiring them — and, just as important, learning how to unlock their embedded value.Ban Jerks to Boost the Bottom Line
A guide to how to go about managing, motivating and inspiring your employees.Banned Horse Trainer Files Civil Rights Suit
Richard Dutrow, who trained Big Brown to Kentucky Derby and Preakness victories in 2008, alleged he was targeted by a biased official and denied due process.
Panel Upholds 10-Year Ban in Race Horse Doping Case
The Third Department said "substantial evidence" supports the charges brought against Kentucky Derby and Preakness-winning trainer Richard Dutrow by the New York State Racing and Wagering Board, and rejected his arguments that a member of the board's disciplinary panel was biased and that the penalty was unduly harsh.TV Lawyers Need a Reality Check
As columnist Tom Alleman languishes with the flu, he has little else to do but compare the working lives of TV lawyers with his own life and notice massively unreal things -- like the fact that TV lawyers don't bring stuff to court. They walk in, sit down and maybe, if it's a super realistic show like "Ally McBeal," they have portfolios and pens.A potent weapon in patent wars
A recent U.S. district court decision invalidating three patents for the controversial painkiller OxyContin is raising questions about a popular defense to patent infringement claims.
Experts 'Frye'd On Tylenol-Cirrhosis Link
In his Products Liability column, Michael Hoenig, a member of Herzfeld & Rubin, analyzes a recent decisions where the court found that the data upon which the plaintiff's experts relied was insufficient to support their novel theory of medical causation, "rendering that theory speculative."TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now